Aclarion, Inc. to Showcase Nociscan at 2024 Maxim Healthcare Virtual Summit

Aclarion, Inc. (Nasdaq: ACON, ACONW), a leader in healthcare technology for chronic low back pain localization, is set to participate in the 2024 Maxim Healthcare Virtual Summit. CEO Brent Ness will present on October 15th, 2024, showcasing the company's flagship product, Nociscan, a groundbreaking SaaS platform for non-invasive diagnosis of chronic low back pain.

The summit, organized by Maxim Group LLC, is a key event for the biotechnology, diagnostic, medical device, and healthcare IT sectors, offering a platform for companies to share innovations and engage with industry leaders. Aclarion's involvement highlights the increasing focus on advanced solutions for chronic pain management, a critical issue affecting millions globally and straining healthcare systems.

Nociscan utilizes Magnetic Resonance Spectroscopy (MRS), proprietary signal processing, biomarkers, and augmented intelligence to differentiate between painful and non-painful discs in the lumbar spine. This cloud-based platform processes MRS data from MRI machines, employing advanced techniques to identify chemical biomarkers linked to disc pain, thereby aiding physicians in developing targeted treatment plans.

The presentation at the Maxim Healthcare Virtual Summit offers investors and healthcare professionals a closer look at Nociscan's capabilities and its potential to enhance patient care and reduce costs. With chronic low back pain being a pervasive challenge, technologies like Nociscan that provide precise diagnostics are vital for improving outcomes.

The virtual format of the summit reflects the healthcare sector's digital transformation, enabling wider participation. Interested parties can register through the M-Vest platform to attend Aclarion's presentation and explore the future of healthcare technology.

Aclarion's participation in the summit underscores the company's role in merging medical expertise with technological innovation to address complex healthcare challenges. The event is an opportunity to discuss how such advancements can transform healthcare delivery and patient outcomes.